Company profile: FIS
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and intermediates, supporting clients from development to commercial production. Offers generic API development and manufacturing, veterinary CDMO, and specialized sterile manufacturing, micronization, lyophilization, and spray drying. Produces 100+ APIs across anticancer, steroids, psychotropics, and veterinary classes.
Products and services
- API Production: FIS produces over 100 active pharmaceutical ingredients across anticancer, steroids, psychotropics, and veterinary classes, delivering industrial-scale batches tailored to diverse therapeutic applications
- CDMO (Contract Development and Manufacturing Organization): FIS provides contract development and manufacturing for APIs and intermediates, custom-engineered to support clients from early development through scale-up and commercial production
- CDMO S (Sterile, Micronization, Lyophilization, Spray Drying): FIS delivers specialized sterile-grade services: sterile manufacturing, micronization, lyophilization, and spray drying for pharmaceutical products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to FIS
BioBridges
HQ: United States
Website
- Description: Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioBridges company profile →
Ology Bio
HQ: United States
Website
- Description: Provider of biologics CDMO services specializing in single-use processes and manufacturing up to BSL-3.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ology Bio company profile →
Inotiv
HQ: United States
Website
- Description: Provider of biopharmaceutical analytical, reproductive toxicology, and medical device testing, offering in vivo preclinical efficacy and toxicity, DMPK method development and bioanalysis, genetic toxicology, histology, and anatomical, clinical, and medical device pathology, plus consulting in DMPK data analysis, biomarker analysis, and bioequivalence to support biologic and small molecule drug development from discovery to First-in-Human.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inotiv company profile →
Konapharma
HQ: Switzerland
Website
- Description: Provider of contract manufacturing services specializing in the production of solid dosage forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Konapharma company profile →
FairJourney Biologics
HQ: Portugal
Website
- Description: Provider of end-to-end antibody discovery and development solutions, leveraging top-tier technologies and seasoned researchers to deliver high-quality, reliable antibodies tailored to partner needs. Services include customized cell line engineering for research and support from discovery to clinical trials; organizer of The Antibody Series on innovations in antibody discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FairJourney Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for FIS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to FIS
2.2 - Growth funds investing in similar companies to FIS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for FIS
4.2 - Public trading comparable groups for FIS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →